Clinical Evaluation of Two Methods for Genotyping Hepatitis C Virus Based on Analysis of the 5' Noncoding Region
about
Update on hepatitis B and C virus diagnosisMatrix-Assisted Laser Desorption Ionization-Time of Flight (Mass Spectrometry) for Hepatitis C Virus GenotypingUse of a commercially available line probe assay for genotyping of hepatitis C virus 5a strains.Evaluation of the invader assay for genotyping hepatitis C virusMultitypic Hepatitis C Virus Infection Identified by Real-Time Nucleotide Sequencing of Minority GenotypesComparative Evaluation of Three Commercially Available Methodologies for Hepatitis C Virus GenotypingImprovement of Hepatitis C Virus (HCV) Genotype Determination with the New Version of the INNO-LiPA HCV AssayUse of Sequence Analysis of the NS5B Region for Routine Genotyping of Hepatitis C Virus with Reference to C/E1 and 5' Untranslated Region SequencesFactors Affecting Serum Concentrations of Hepatitis C Virus (HCV) RNA in HCV Genotype 1-Infected Patients with Chronic HepatitisEvaluation of a New Assay in Comparison with Reverse Hybridization and Sequencing Methods for Hepatitis C Virus Genotyping Targeting Both 5' Noncoding and Nonstructural 5b Genomic RegionsEvaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0Evaluation of the TRUGENE HCV 5'NC Genotyping Kit with the New GeneLibrarian Module 3.1.2 for Genotyping of Hepatitis C Virus from Clinical SpecimensHCV genotyping using statistical classification approachHepatitis C Virus (HCV) Genotype 1 Subtype Identification in New HCV Drug Development and Future Clinical PracticeClinical Laboratory Testing in the Era of Directly Acting Antiviral Therapies for Hepatitis CComparison of hepatitis C virus NS5b and 5' noncoding gene sequencing methods in a multicenter study.Controversies in and challenges to our understanding of hepatitis C.Hepatitis C virus genotypes in clinical specimens tested at a national reference testing laboratory in the United States.Hepatitis B and C virus infections among patients with end stage renal disease in a low-resourced hemodialysis center in Vietnam: a cross-sectional study.Comparative performance evaluation of hepatitis C virus genotyping based on the 5' untranslated region versus partial sequencing of the NS5B region of brazilian patients with chronic hepatitis C.Comparison of Three Different Hepatitis C Virus Genotyping Methods: 5'NCR PCR-RFLP, Core Type-Specific PCR, and NS5b Sequencing in a Tertiary Care Hospital in South India.Molecular methods of hepatitis C genotyping.Hepatitis C virus (HCV) genotypes in the Caribbean island of Martinique: evidence for a large radiation of HCV-2 and for a recent introduction from Europe of HCV-4Development and Application of an In-house Line Probe Assay for Hepatitis C Virus GenotypingSequencing assays for failed genotyping with the versant hepatitis C virus genotype assay (LiPA), version 2.0.Hepatitis C Virus NS5B Sequence-Based Genotyping Analysis of Patients From the Sharkia Governorate, Egypt.Advances in the Diagnosis and Monitoring of Hepatitis C Virus Infection.Molecular Assay and Genotyping of Hepatitis C Virus among Infected Egyptian and Saudi Arabian Patients.Characterization of Samples Identified as Hepatitis C Virus Genotype 1 without Subtype by Abbott RealTime HCV Genotype II Assay Using the New Abbott HCV Genotype Plus RUO Test.Hepatitis C virus genotyping methods: evaluation of AmpliSens(®) HCV-1/2/3-FRT compared to sequencing method.Hepatitis C virus genotype 4 in Southern and Central Spain does not originate from recent foreign migration waves.Correlation of the 5'untranslated region (5'UTR) and non-structural 5B (NS5B) nucleotide sequences in hepatitis C virus subtyping.Identification of rare hepatitis C virus genotype 5a among Indian population.Hepatitis C virus genotypes in hemodialysis patients in the Federal District, Brazil.Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam.Development and evaluation of an automated hepatitis C virus NS5B sequence-based subtyping assay.Determination of the hepatitis C virus subtype: comparison of sequencing and reverse hybridization assays.Genotyping hepatitis C virus from hemodialysis patients in Central Brazil by line probe assay and sequence analysis.
P2860
Q26777048-00595175-6B6D-4BE9-99CD-D4EFFAEA4130Q27469972-870C692F-647B-4545-B8EF-F09531B45E0AQ27472773-C52AE8DE-51C2-4F9F-9E58-1E67128AF058Q27473033-3E1EC5A0-5F54-407B-B5A1-275FEF2D6A0FQ27477500-4443DE2B-1EFF-49F3-9006-28898922DFBDQ27477505-33855553-D417-4DCE-AFA3-5E2CB8903FABQ27478358-7C2A3390-B50E-49BC-B88B-04C5445708B5Q27478359-B3E02BC3-2804-4E28-A54D-5831263C4264Q27480999-BD8C0FD9-90D5-45F7-B983-781E2914069BQ27485290-7ECDC8E3-2524-4A7B-B4A2-EE3F383A3F4AQ27486402-49544D3B-F9ED-426C-8E38-696F64A29953Q27486902-2ACF4153-2B57-4FF3-A2D2-A906E13C741DQ27489079-19C834EF-90EB-4DF1-A14D-391F9A179899Q27490447-417D6A0F-EB6C-41A8-842F-2802C25C82EAQ28080225-23275153-3D3A-459C-94D5-EADB25547D17Q33825378-78233A9E-DB8A-4BE8-8273-916C0F66C7C4Q34604806-91DBA581-9519-49E3-9B07-3D2293A07A12Q35139900-CAAB538B-423B-4120-AFA6-228530A5360FQ35141866-53586C5A-A167-470F-A27B-B6A762E5F6C0Q35505377-088D8D1D-855C-43B8-A84C-F9484E45F0C6Q36118779-D1F91CE9-AC0E-40B3-A006-459FF318FEC6Q36192689-A73B446C-297B-487D-957E-B6AD198F557BQ36240052-DF25FB41-CC86-43B1-BF27-D0ACE2435C2FQ37073862-5E85221C-C2BD-45C0-869D-CE43EEE2888FQ37125237-B97DE63F-C023-4F23-8284-636D708E4DE7Q37401168-2E20D37F-83BF-467F-80CF-523CEDA5741CQ38992041-74A9064C-E9FA-46C9-9BF4-A320F885DA59Q40381500-1E84B473-DB09-4373-957C-66A7F3234DA8Q41114226-B8DB7243-4D50-476B-BA4C-0299932C2908Q42240147-EC00F544-3B0D-48FB-A768-38EDD9981851Q42254820-4146B2EC-A4B7-4FC4-BB4C-20425772B281Q42716855-FF30B18F-5EA2-4CFD-BE74-4E002C8D5DBDQ42991094-2A2B3720-1F6A-434A-AB1F-D2EC8EFE154EQ42995674-23940364-611D-46CC-912E-76A207123BB6Q42997917-36196243-C06D-4F20-8A68-64D5BFD0EE90Q42998028-97818490-8148-4C09-B9C5-897D0C572F85Q43036114-5C365C07-64FB-47ED-90BC-0E2018A5398FQ43036883-2DA55FD9-E618-44F9-BCA2-3F13CFD05CCC
P2860
Clinical Evaluation of Two Methods for Genotyping Hepatitis C Virus Based on Analysis of the 5' Noncoding Region
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Clinical Evaluation of Two Met ...... sis of the 5' Noncoding Region
@ast
Clinical Evaluation of Two Met ...... sis of the 5' Noncoding Region
@en
Clinical Evaluation of Two Met ...... sis of the 5' Noncoding Region
@nl
type
label
Clinical Evaluation of Two Met ...... sis of the 5' Noncoding Region
@ast
Clinical Evaluation of Two Met ...... sis of the 5' Noncoding Region
@en
Clinical Evaluation of Two Met ...... sis of the 5' Noncoding Region
@nl
prefLabel
Clinical Evaluation of Two Met ...... sis of the 5' Noncoding Region
@ast
Clinical Evaluation of Two Met ...... sis of the 5' Noncoding Region
@en
Clinical Evaluation of Two Met ...... sis of the 5' Noncoding Region
@nl
P2093
P2860
P1476
Clinical Evaluation of Two Met ...... sis of the 5' Noncoding Region
@en
P2093
Aileen Grunwald
Alicia M Green
Angela M Caliendo
Cynthia Sturchio
Frederick S Nolte
Kristin R Fiebelkorn
Mimi Healy
P2860
P304
P356
10.1128/JCM.41.4.1558-1564.2003
P407
P577
2003-04-01T00:00:00Z